GB969263A - Novel derivatives of thebaine and oripavine - Google Patents

Novel derivatives of thebaine and oripavine

Info

Publication number
GB969263A
GB969263A GB821962A GB821962A GB969263A GB 969263 A GB969263 A GB 969263A GB 821962 A GB821962 A GB 821962A GB 821962 A GB821962 A GB 821962A GB 969263 A GB969263 A GB 969263A
Authority
GB
United Kingdom
Prior art keywords
group
hydrogen atom
symbol
carbon atoms
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB821962A
Inventor
Kenneth Walter Bentley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
J F Macfarlan & Co Ltd
Original Assignee
J F Macfarlan & Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NL289751D priority Critical patent/NL289751A/xx
Priority to GB821962A priority patent/GB969263A/en
Application filed by J F Macfarlan & Co Ltd filed Critical J F Macfarlan & Co Ltd
Priority to DE19631470037 priority patent/DE1470037C/en
Priority to DE19631795591 priority patent/DE1795591A1/en
Priority to SE228863A priority patent/SE307138B/xx
Publication of GB969263A publication Critical patent/GB969263A/en
Priority to US478738A priority patent/US3474101A/en
Priority to MY6600072A priority patent/MY6600072A/en
Priority to US726591A priority patent/US3433791A/en
Priority to US726592A priority patent/US3442900A/en
Priority to NL696903699A priority patent/NL140528B/en
Priority to NL6903698A priority patent/NL138131C/xx
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention comprises thebaine and oripuvine derivatives of the formula: <FORM:0969263/C1/1> where the symbol R represents a hydrogen atom or a methyl group or an acyl group CnH2n+1 CO- where n is an integer; R1 represents a hydrogen atom or an alkyl or alkenyl group containing 2 to 8 carbon atoms, a propargyl, cyclopropylmethyl, methylcyclopropyl methyl or dimethylcyclopropylmethyl group; R2 represents a hydrogen atom or an alkyl group of up to 3 carbon atoms or an aryl group and R3 represents a hydrogen atom, an alicyclic group of 5, 6 or 7 carbon atoms or an alkyl or alkenyl group of up to eight carbon atoms which may be substituted on carbon atoms 1 to 4 by an alicyclic; aryl, alkoxy, aryloxy or heterocyclic group containing oxygen such that when R represents a hydrogen atom or an acyl group or when R1 represents a hydrogen atom, a cyclopropylmethyl, methyl cyclopropylmethyl or a dimethylcyclopropylmethyl group, R3 does not contain the system -CHAryl or -CH-C=C attached directly to the carbon atom bearing the alcoholic hydroxyl group; and salts thereof with pharmaceutically acceptable acids. The invention also includes a process for the preparation of compounds of the above general formula in which compounds of the above general formula where the group represented by symbol R3 does not contain the system -CHAryl or -CH-C=C linked directly to the carbon atoms bearing the alcoholic hydroxyl group and the symbols R and R1 represent methyl groups are treated with cyanogen bromide and the resulting N-cyano compound hydrolysed with an alkali metal hydroxide or alkoxide in a solvent to give a secondary amine of the above formula (R1 is H) which is converted to a tert. amine by treatment with an alkyl, alkenyl, cycloalkyl or propargyl halide or with an acyl halide followed by reduction of the resulting N-acyl compound with lithium aluminium hydride (when the hydrolysis is carried out at temperatures up to 180 DEG C. a product is obtained in which the symbol R represents a methyl group, and at temperatures above 180 DEG C. a product is obtained in which the symbol R represents a hydrogen atom); a process for the preparation compounds of the above general formula where the symbol R represents a methyl group and R1 represents one of n-propyl, isobutyl, alkyl, methylallyl, dimethylallyl and propargyl in which a compound of the general formula: <FORM:0969263/C1/2> is treated with a Grignard reagent R3MgX when the symbol X represents a halogen atom (in this process the reactants of the general formula immediately above wherein R is a methyl group, R1 is a n-propyl, isobutyl, allyl, methylallyl, dimethylallyl or propargyl group and R2 has the above significance may be prepared from the corresponding compounds in which R1 represents the methyl group by treatment with cyanogen bromide and the resulting N-cyano compound in which R1 is cyano is treated successively with dilute mineral acid, sodium nitrate and ammonia to form a secondary amine (R1 is hydrogen) and this compound is reacted with a n-propyl, isobutyl, allyl, methylallyl, dimethylallyl or propargyl halide); and processes for the preparation of the compounds of the first formula above wherein R represents CnH2n+1CO- (n is an integer) in which the corresponding compounds wherein R represents hydrogen are heated under reflux with the required acid anhydride and an alkali metal salt of the corresponding acid or are heated with an aqueous solution of an alkali metal hydroxide and a halide or anhydride of the required acid. Specifications 902,659 and 925,723 are referred to.
GB821962A 1960-09-05 1962-03-02 Novel derivatives of thebaine and oripavine Expired GB969263A (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
NL289751D NL289751A (en) 1962-03-02
GB821962A GB969263A (en) 1962-03-02 1962-03-02 Novel derivatives of thebaine and oripavine
DE19631470037 DE1470037C (en) 1962-03-02 1963-03-01 Oripavindenvate
DE19631795591 DE1795591A1 (en) 1962-03-02 1963-03-01 Thebaine derivatives and drugs
SE228863A SE307138B (en) 1962-03-02 1963-03-01
US478738A US3474101A (en) 1960-09-05 1965-08-10 Thebaine and oripavine derivatives
MY6600072A MY6600072A (en) 1962-03-02 1966-12-31 Novel derivatives of thebaine and oripavine
US726591A US3433791A (en) 1960-09-05 1968-05-03 Endoethano nor oripavines and nor thebaines
US726592A US3442900A (en) 1960-09-05 1968-05-03 Endoetheno thebaines and oripavines
NL696903699A NL140528B (en) 1962-03-02 1969-03-10 PROCESS FOR PREPARING DERIVATIVES OF THEBAINE AND ORIPAVINE.
NL6903698A NL138131C (en) 1962-03-02 1969-03-10

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB821962A GB969263A (en) 1962-03-02 1962-03-02 Novel derivatives of thebaine and oripavine

Publications (1)

Publication Number Publication Date
GB969263A true GB969263A (en) 1964-09-09

Family

ID=9848224

Family Applications (1)

Application Number Title Priority Date Filing Date
GB821962A Expired GB969263A (en) 1960-09-05 1962-03-02 Novel derivatives of thebaine and oripavine

Country Status (3)

Country Link
GB (1) GB969263A (en)
MY (1) MY6600072A (en)
NL (2) NL138131C (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3285914A (en) * 1964-06-11 1966-11-15 Smith Kline French Lab 3-n-substituted derivatives of oripavine and thebaine
US3318885A (en) * 1965-07-21 1967-05-09 American Cyanamid Co Substituted 6-amino-6, 14-endoethen-ocodides and morphides
US3474101A (en) * 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
US3474103A (en) * 1967-12-08 1969-10-21 American Cyanamid Co Substituted 7-acryloyl - 7,8 - dihydro-6-(hydroxy or methoxy)-6,14-endo(etheno or ethano) codides and morphides
US3474102A (en) * 1967-12-08 1969-10-21 American Cyanamid Co Substituted 7 - (2 - formyl-1-alkoxyvinyl)-7,8-dihydro-6-(hydroxy or methoxy)-6,14-endo (etheno or ethano) codides and morphides
WO2013007986A1 (en) 2011-07-08 2013-01-17 The University Of Bath Orvinol and thevinol derivatives useful in the treatment of drug and alcohol abuse
US8530494B2 (en) 2008-07-30 2013-09-10 Purdue Pharma Lp Buprenophine analogs
US9315514B2 (en) 2012-08-27 2016-04-19 Rhodes Technologies 1,3-dioxanomorphides and 1,3-dioxanocodides

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3474101A (en) * 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
US3285914A (en) * 1964-06-11 1966-11-15 Smith Kline French Lab 3-n-substituted derivatives of oripavine and thebaine
US3318885A (en) * 1965-07-21 1967-05-09 American Cyanamid Co Substituted 6-amino-6, 14-endoethen-ocodides and morphides
US3474103A (en) * 1967-12-08 1969-10-21 American Cyanamid Co Substituted 7-acryloyl - 7,8 - dihydro-6-(hydroxy or methoxy)-6,14-endo(etheno or ethano) codides and morphides
US3474102A (en) * 1967-12-08 1969-10-21 American Cyanamid Co Substituted 7 - (2 - formyl-1-alkoxyvinyl)-7,8-dihydro-6-(hydroxy or methoxy)-6,14-endo (etheno or ethano) codides and morphides
US8530494B2 (en) 2008-07-30 2013-09-10 Purdue Pharma Lp Buprenophine analogs
WO2013007986A1 (en) 2011-07-08 2013-01-17 The University Of Bath Orvinol and thevinol derivatives useful in the treatment of drug and alcohol abuse
JP2015172089A (en) * 2011-07-08 2015-10-01 ザ ユニバーシティ オブ バース Orvinol and thevinol derivatives useful in the treatment of drug and alcohol abuse
US9315514B2 (en) 2012-08-27 2016-04-19 Rhodes Technologies 1,3-dioxanomorphides and 1,3-dioxanocodides

Also Published As

Publication number Publication date
MY6600072A (en) 1966-12-31
NL138131C (en) 1969-03-10
NL6903698A (en) 1969-05-27
NL289751A (en)

Similar Documents

Publication Publication Date Title
GB969263A (en) Novel derivatives of thebaine and oripavine
KR840004102A (en) Method for preparing quinoline compound
GB1535295A (en) Process for producing hydrogen
FR2366273A1 (en) PROCESS FOR PREPARING ARYLSULFONIUM SALTS
ES462346A1 (en) Amidoxime derivatives
ES8602826A1 (en) Process for preparing cyclic phosphorous-acid esters.
GB1116595A (en) Codeine and morphine derivatives
ES463783A1 (en) Cis-4a-phenyl-2,3,4,4a,5,6,7,7a-octahydro-1h-2-pyrindines and pharmaceutical compositions containing them
GB1251873A (en)
GB913578A (en) Preparation of tetracycline and tetracycline-urea compounds
DE2964836D1 (en) Phthalide-isoquinoline derivatives, their preparation and their use in medicaments
ES278409A1 (en) Procedure for preparing new amino acids (Machine-translation by Google Translate, not legally binding)
GB962324A (en) Steroid compounds and production thereof
GB1066300A (en) Process for the preparation of phenyl-cyclohexyl-alkylamines
Ermakova et al. Synthesis in the phenothiazine series: XXXVI. Quaternary salts of imidazo [4, 5, 1-k, l] phenothiazine and their transformations
GB1010231A (en) Substituted 3-phenyl-5-imino-4,5 dihydro-1,2,4-oxadiazoles, process for their manufacture and therapeutic compositions containing same
ES405171A1 (en) Process for the preparation of 3- beta-dialkyl-aminoethyl - 4-alkyl -7-carboethoxymethoxycoumarins
JPS6337104B2 (en)
GB974894A (en) Process for the production of amine compounds
ES352202A1 (en) 6,14-endoetheno northebaines and nororipavines
GB948882A (en) Process for preparing borazoles
ES410009A1 (en) Process for preparing 7-acylamino-3-substituted-3-cephem-4- carboxylic acid derivatives
ES413742A1 (en) Derivatives of alpha-halo-alpha-benzyl propionic acid
SE8100127L (en) PROCEDURE FOR PREPARING IMIDAZOLD DERIVATIVES
GB1097360A (en) Preparation of methylene glutaronitrile derivatives